PAWC
P.A.W. Capital Portfolio holdings
AUM
$51.9M
This Quarter Return
-0.32%
1 Year Return
+46.14%
3 Year Return
+74.13%
5 Year Return
+167.35%
10 Year Return
+839.74%
AUM
$109M
AUM Growth
+$109M
(-3%)
Cap. Flow
+$682K
Cap. Flow
% of AUM
0.63%
Top 10 Holdings %
Top 10 Hldgs %
48.05%
Holding
68
New
5
Increased
17
Reduced
21
Closed
8
Top Buys
| 1 |
Magnite
MGNI
|
$2.63M |
| 2 |
ON24
ONTF
|
$2.6M |
| 3 |
indie Semiconductor
INDI
|
$2.4M |
| 4 |
Chegg
CHGG
|
$1.69M |
| 5 |
PENG
Penguin Solutions, Inc. Ordinary Shares
PENG
|
$1.42M |
Top Sells
| 1 |
Ambarella
AMBA
|
$2.03M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$1.85M |
| 3 |
C4 Therapeutics
CCCC
|
$1.79M |
| 4 |
LivePerson
LPSN
|
$1.47M |
| 5 |
Ryvyl
RVYL
|
$1.41M |
Sector Composition
| 1 | Technology | 35.99% |
| 2 | Communication Services | 16.8% |
| 3 | Healthcare | 15.05% |
| 4 | Industrials | 12.61% |
| 5 | Consumer Staples | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cisco
CSCO
$268B
| $951K | 0.87% |
15,000
| – | – |
|
27
AbbVie
ABBV
$374B
| $948K | 0.87% |
7,000
| – | – |
|
28
Pfizer
PFE
$141B
| $945K | 0.87% |
16,000
-2,000
| -11% | -$118K |
|
29
Chevron
CVX
$318B
| $939K | 0.86% |
8,000
-1,000
| -11% | -$117K |
|
30
Bristol-Myers Squibb
BMY
$96.7B
| $935K | 0.86% |
15,000
+3,000
| +25% | +$187K |
|
31
Amgen
AMGN
$153B
| $900K | 0.83% |
+4,000
| New | +$900K |
|
32
Procter & Gamble
PG
$370B
| $900K | 0.83% |
5,500
-500
| -8% | -$81.8K |
|
33
Western Union
WU
$2.82B
| $892K | 0.82% |
+50,000
| New | +$892K |
|
34
Lockheed Martin
LMT
$105B
| $889K | 0.82% |
2,500
+300
| +14% | +$107K |
|
35
Omega Healthcare
OHI
$12.5B
| $888K | 0.81% |
+30,000
| New | +$888K |
|
36
GSK
GSK
$79.3B
| $882K | 0.81% |
16,000
| – | – |
|
37
Merck
MRK
$210B
| $881K | 0.81% |
11,500
-500
| -4% | -$38.3K |
|
38
JPMorgan Chase
JPM
$824B
| $871K | 0.8% |
5,500
| – | – |
|
39
PepsiCo
PEP
$203B
| $869K | 0.8% |
5,000
-500
| -9% | -$86.9K |
|
|
RDS.A
40
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $868K | 0.8% |
20,000
| – | – |
|
41
Prudential Financial
PRU
$37.8B
| $866K | 0.79% |
8,000
| – | – |
|
42
Unum
UNM
$12.4B
| $860K | 0.79% |
35,000
+2,000
| +6% | +$49.1K |
|
43
Exxon Mobil
XOM
$477B
| $857K | 0.79% |
14,000
-1,000
| -7% | -$61.2K |
|
44
Johnson & Johnson
JNJ
$429B
| $855K | 0.78% |
5,000
| – | – |
|
45
Philip Morris
PM
$254B
| $855K | 0.78% |
9,000
| – | – |
|
46
Varonis Systems
VRNS
$6.21B
| $854K | 0.78% |
17,500
-12,500
| -42% | -$610K |
|
47
Altria Group
MO
$112B
| $853K | 0.78% |
18,000
+1,000
| +6% | +$47.4K |
|
48
Dow Inc
DOW
$17B
| $851K | 0.78% |
15,000
+2,000
| +15% | +$113K |
|
49
Ares Capital
ARCC
$15.7B
| $848K | 0.78% |
40,000
| – | – |
|
50
Abbott
ABT
$230B
| $844K | 0.77% |
6,000
| – | – |
|